Baytril 25 mg/ml Solution for Injection

Riik: Suurbritannia

keel: inglise

Allikas: VMD (Veterinary Medicines Directorate)

Toimeaine:

Enrofloxacin

Saadav alates:

Bayer plc

ATC kood:

QJ01MA90

INN (Rahvusvaheline Nimetus):

Enrofloxacin

Ravimvorm:

Solution for injection

Retsepti tüüp:

POM-V - Prescription Only Medicine – Veterinarian

Terapeutiline rühm:

Cats, Dogs, Ornamental Birds, Pigs, Rabbits, Reptiles, Rodents

Terapeutiline ala:

Antimicrobial

Volitamisolek:

Authorized

Loa andmise kuupäev:

1992-04-22

Toote omadused

Revised: May 2017
AN: 00069/2017
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Baytril 25 mg/ml solution for injection
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
One ml solution contains:
ACTIVE SUBSTANCE:
Enrofloxacin 25 mg
EXCIPIENT:
n-Butyl alcohol30 mg.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Solution for injection.
Clear light-yellow solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Dogs, cats, pigs (piglets), rabbits, rodents, reptiles and ornamental
birds.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
DOGS
Treatment of infections of the alimentary, respiratory and urogenital
tracts
(including prostatitis, adjunctive antibiotic therapy for pyometra),
skin and
wound infections, otitis (externa/media) caused by enrofloxacin
susceptible
strains of:_ Staphylococcus _spp_., Escherichia coli, Pasteurella
_spp_., Klebsiella _
spp_., Bordetella _spp_., Pseudomonas _spp_._ and_ Proteus _spp_._
CATS
Treatment of infections of the alimentary, respiratory and urogenital
tracts (as
adjunctive antibiotic therapy for pyometra), skin and wound
infections, caused
by enrofloxacin susceptible strains of:_ Staphylococcus _spp_.,
Escherichia coli, _
_Pasteurella _spp_., Klebsiella _spp_., Bordetella _spp_., Pseudomonas
_spp_._ and_ _
_Proteus _spp.
PIGS (PIGLETS)
Treatment of infections of the respiratory tract caused by
enrofloxacin
susceptible strains of: _Pasteurella_ _multocida,_ _Mycoplasma_
spp_.,_ _Actinobacillus _
_pleuropneumoniae_.
1
Revised: May 2017
AN: 00069/2017
Treatment of infections of the alimentary tract caused by enrofloxacin
susceptible strains of _Escherichia coli._
Treatment of septicaemia caused by enrofloxacin susceptible strains of
_Escherichia coli_.
RABBITS
Treatment of infections of the alimentary and respiratory tracts
caused by
enrofloxacin susceptible strains of: _Escherichia coli_, _Pasteurella
multocida_ and
_Staphylococcus_ spp.
Treatment of skin and wound infections caused by_ _enrofloxacin
susceptible
strains of _